{"id":415527,"title":"Guidance Document - Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-26","captureTimestamp":"2026-01-26T11:48:57.367000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-requirements-extraordinary-drugs-eunds.html","snippet":"Guidance Document - Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs) On this page Overview Applicable regulations Clinical trial applications Submission information and requirements Post-market requirements Labelling Changes following…","rawSnapshotUrl":"/api/snapshots/raw/415527","browseUrl":"https://replay.healtharchive.ca/job-6/20260126114857/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-requirements-extraordinary-drugs-eunds.html#ha_snapshot=415527","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}